Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in ZTS — Zoetis Inc.

CIK 1179392 NEW YORK, NY
Back to ZTS Full portfolio

Position in ZTS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$27,768,716
+$10,947,433 QoQ
Shares Held
386,428
+171.6% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Derivatives in ZTS

reported options exposure · as of Jun 30, 2026
CallValue
$1,739,012
CallShares
24,200
PutValue
$1,875,546
PutShares
26,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. ZTS ranks #6 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 2,076,260 $349,932,860
2 BCRX
Biocryst Pharmaceuticals Inc
 6,775,349 $67,753,490
3 SUPN
Supernus Pharmaceuticals, Inc.
 1,184,378 $55,085,420
4 ALKS
Alkermes plc.
 1,038,311 $54,407,496
5 KNSA
Kiniksa Pharmaceuticals International, plc
 561,480 $35,906,646
6 ZTS
Zoetis Inc.
This page 		386,428 $27,768,716
7 LQDA
Liquidia Corp
 266,829 $21,274,276
8 IRWD
Ironwood Pharmaceuticals Inc
 4,556,089 $19,181,134

All Filings in ZTS

Export CSV
44 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,875,546 26,100
2026-06-30 $1,739,012 24,200
2026-06-30 $27,768,716 386,428
2026-03-31 $16,821,283 142,300
2026-03-31 $1,796,792 15,200
2026-03-31 $2,068,675 17,500
2025-12-31 $13,930,538 110,718
2025-09-30 $16,620,781 113,592
2025-06-30 $2,154,293 13,814
2025-03-31 $16,945,613 102,919
2024-12-31 $22,523,280 138,239
2024-09-30 $3,686,234 18,867
2024-06-30 $24,065,488 138,818
2024-03-31 $71,302,386 421,384
2023-12-31 $7,271,702 36,843
2023-09-30 $3,162,782 18,179
2023-06-30 $31,075,638 180,452
2023-03-31 $24,148,946 145,091
2022-12-31 $36,619,620 249,878
2022-09-30 $58,227,996 392,663
2022-06-30 $91,783,587 533,967
2022-03-31 $229,095,925 1,214,783
2021-12-31 $2,147,464 8,800
2021-12-31 $142,018,627 581,972
2021-12-31 $1,561,792 6,400
2021-09-30 $1,358,980 7,000
2021-09-30 $103,298,787 532,084
2021-09-30 $1,708,432 8,800
2021-06-30 $44,685,400 239,780
2021-03-31 $992,124 6,300
2021-03-31 $98,079,173 622,804
2021-03-31 $314,960 2,000
2020-12-31 $25,652,665 155,001
2020-12-31 $711,650 4,300
2020-12-31 $331,000 2,000
2020-09-30 $512,647 3,100
2020-09-30 $529,184 3,200
2020-09-30 $2,979,636 18,018
2020-06-30 $1,249,530 9,118
2020-06-30 $1,466,328 10,700
2020-06-30 $1,137,432 8,300
2020-03-31 $1,129,824 9,600
2020-03-31 $588,450 5,000
2020-03-31 $1,372,147 11,659